ABSTRACT
Study Objectives: Experimental studies over the last 15 years established a role in sleep of the tuberal hypothalamic neurons that express melanin-concentrating hormone (MCH). Controversies still remain regarding their actual contribution to both slow-wave sleep (SWS) and paradoxical sleep (PS also known as REM sleep) or PS alone. Methods: To address this point, we compared effects of chemogenetic activation and inhibition of MCH neurons on SWS and PS amounts and EEG rhythmic activities in transgenic Pmch-cre mice. Results: In agreement with recently reported optogenetic data, the activation of MCH neurons invariably facilitates PS onset and maintenance. Our chemogenetic experiments further disclose that the ultradian rhythm of SWS is also notably related to the activity of MCH neurons. We observed that the mean duration of SWS episodes is significantly extended when MCH neurons are inhibited. Conversely, when they were excited, SWS bouts were drastically shortened and depicted substantial changes in δ rhythmic activities in electroencephalographic recording likely reflecting a deeper SWS. Conclusions: According to these original findings, we propose that when MCH neurons are physiologically recruited, SWS depth is increased and the extinction of SWS episodes is accelerated, two joint physiological processes strengthening the probability for natural SWS to PS transition and likely facilitating PS onset.
Subject(s)
Electroencephalography/methods , Hypothalamic Hormones/biosynthesis , Melanins/biosynthesis , Neurons/metabolism , Pituitary Hormones/biosynthesis , Sleep, REM/physiology , Sleep, Slow-Wave/physiology , Animals , Gene Expression , Hypothalamic Hormones/genetics , Hypothalamus/physiology , Male , Melanins/genetics , Mice , Mice, Inbred C57BL , Mice, Transgenic , Optogenetics/methods , Pituitary Hormones/genetics , Sleep/physiology , Ultradian Rhythm/physiologyABSTRACT
Acupuncture has shown the therapeutic effect on various neurodegenerative disorders including Parkinson's disease (PD). While investigating the neuroprotective mechanism of acupuncture, we firstly found the novel function of melanin-concentrating hormone (MCH) as a potent neuroprotective candidate. Here, we explored whether hypothalamic MCH mediates the neuroprotective action of acupuncture. In addition, we aimed at evaluating the neuroprotective effects of MCH and elucidating underlying mechanism in vitro and in vivo PD models. First, we tested whether hypothalamic MCH mediates the neuroprotective effects of acupuncture by challenging MCH-R1 antagonist (i.p.) in mice PD model. We also investigated whether MCH has a beneficial role in dopaminergic neuronal protection in vitro primary midbrain and human neuronal cultures and in vivo MPTP-induced, Pitx3-/-, and A53T mutant mice PD models. Transcriptomics followed by quantitative PCR and western blot analyses were performed to reveal the neuroprotective mechanism of MCH. We first found that hypothalamic MCH biosynthesis was directly activated by acupuncture treatment and that administration of an MCH-R1 antagonist reverses the neuroprotective effects of acupuncture. A novel finding is that MCH showed a beneficial role in dopaminergic neuron protection via downstream pathways related to neuronal survival. This is the first study to suggest the novel neuroprotective action of MCH as well as the involvement of hypothalamic MCH in the acupuncture effects in PD, which holds great promise for the application of MCH in the therapy of neurodegenerative diseases.
Subject(s)
Acupuncture Therapy/methods , Hypothalamic Hormones/biosynthesis , Melanins/biosynthesis , Neuroprotective Agents/metabolism , Parkinsonian Disorders/metabolism , Parkinsonian Disorders/prevention & control , Pituitary Hormones/biosynthesis , Animals , Cells, Cultured , Humans , Hypothalamic Hormones/administration & dosage , Hypothalamic Hormones/antagonists & inhibitors , Hypothalamus/metabolism , Male , Melanins/administration & dosage , Melanins/antagonists & inhibitors , Mice , Mice, Inbred C57BL , Mice, Transgenic , Pituitary Hormones/administration & dosage , Pituitary Hormones/antagonists & inhibitors , Treatment OutcomeABSTRACT
BACKGROUND: Reward and energy homeostasis are both regulated by a network of hypothalamic neuropeptide systems. The melanin-concentrating hormone (MCH) and its MCH-1 receptor (MCH1-R) modulate alcohol intake, but it remains unknown to what extent this reflects actions on energy balance or reward. Here, we evaluated the MCH1-R in regulation of caloric intake and motivation to consume alcohol in states of escalated consumption. METHODS: Rats had intermittent access (IA) to alcohol and were divided into high- and low-drinking groups. Food and alcohol consumption was assessed after administration of an MCH1-R antagonist, GW803430. Next, GW803430 was evaluated on alcohol self-administration in protracted abstinence induced by IA in high-drinking rats. Finally, the effect of GW803430 was assessed on alcohol self-administration in acute withdrawal in rats exposed to alcohol vapor. Gene expression of MCH and MCH1-R was measured in the hypothalamus and nucleus accumbens (NAc) in both acute and protracted abstinence. RESULTS: High-drinking IA rats consumed more calories from alcohol than chow and GW803430 decreased both chow and alcohol intake. In low-drinking rats, only food intake was affected. In protracted abstinence from IA, alcohol self-administration was significantly reduced by pretreatment with GW803430 and gene expression of both MCH and the MCH1-R were dysregulated in hypothalamus and NAc. In contrast, during acute withdrawal from vapor exposure, treatment with GW803430 did not affect alcohol self-administration, and no changes in MCH or MCH1-R gene expression were observed. CONCLUSIONS: Our data suggest a dual role of MCH and the MCH1-R in regulation of alcohol intake, possibly through mechanisms involving caloric intake and reward motivation. A selective suppression of alcohol self-administration during protracted abstinence by GW803430 was observed and accompanied by adaptations in gene expression of MCH and MCH1-R. Selective suppression of escalated consumption renders the MCH1-R an attractive target for treatment of alcohol use disorders.
Subject(s)
Alcohol Drinking/physiopathology , Energy Intake/physiology , Hypothalamic Hormones/physiology , Melanins/physiology , Motivation/physiology , Pituitary Hormones/physiology , Receptors, Somatostatin/physiology , Animals , Eating/physiology , Gene Expression/drug effects , Gene Expression/physiology , Hypothalamic Hormones/biosynthesis , Hypothalamus/metabolism , Male , Melanins/biosynthesis , Nucleus Accumbens/metabolism , Pituitary Hormones/biosynthesis , Pyrimidinones/pharmacology , Rats , Receptors, Somatostatin/antagonists & inhibitors , Self Administration , Thiophenes/pharmacologyABSTRACT
AIMS: Melanin-concentrating hormone (MCH) is implicated in the control of food intake, body weight regulation and energy homeostasis. Lactation is an important physiological model to study the hypothalamic integration of peripheral sensory signals, such as suckling stimuli and those related to energy balance. MCH can be detected in the medial preoptic area (MPOA), especially around the 19th day of lactation, when this hormone is described as displaying a peak synthesis followed by a decrease after weaning. The physiological significance of this phenomenon is unclear. Therefore, we aimed to investigate hypothalamic changes associated to sensory stimulation by the litter, in special its influence over MCH synthesis. MAIN METHODS: Female Wistar rats (n=56) were euthanized everyday from lactation days 15-21, with or without suckling stimulus (WS and NS groups, respectively). MCH and Fos immunoreactivity were evaluated in the MPOA and lateral and incerto-hypothalamic areas (LHA and IHy). KEY FINDINGS: Suckling stimulus induced Fos synthesis in all regions studied. An increase on the number of suckling-induced Fos-ir neurons could be detected in the LHA after the 18th day. Conversely, the amount of MCH decreased in the MPOA from days 15-21, independent of suckling stimulation. No colocalization between MCH and Fos could be detected in any region analyzed. SIGNIFICANCE: Suckling stimulus is capable of stimulating hypothalamic regions not linked to maternal behavior, possibly to mediate energy balance aspects of lactation. Although dams are hyperphagic before weaning, this behavioral change does not appear to be mediated by MCH.
Subject(s)
Hypothalamic Hormones/biosynthesis , Hypothalamus/metabolism , Lactation/metabolism , Melanins/biosynthesis , Melanophores/metabolism , Pituitary Hormones/biosynthesis , Proto-Oncogene Proteins c-fos/biosynthesis , Animals , Animals, Suckling , Female , Hypothalamic Hormones/analysis , Melanins/analysis , Pituitary Hormones/analysis , Proto-Oncogene Proteins c-fos/analysis , Rats , Rats, WistarABSTRACT
The hypothalamic-pituitary (H-P) axis integrates complex physiological and environmental signals and responds to these cues by modulating the synthesis and secretion of multiple pituitary hormones to regulate peripheral tissues. Prostaglandins are a component of this regulatory system, affecting multiple hormone synthesis and secretion pathways in the H-P axis. The implications of these actions are that physiological processes or disease states that alter prostaglandin levels in the hypothalamus or pituitary can impinge on H-P axis function. Considering the role of prostaglandins in mediating inflammation, the potential for neuroinflammation to affect H-P axis function in this manner may be significant. In addition, the mitigating effects of n-3 polyunsaturated fatty acids (n-3 PUFA) on the inflammation-associated synthesis of prostaglandins and their role as substrates for pro-resolving lipid mediators may also include effects in the H-P axis. One context in which neuroinflammation may play a role is in the etiology of diet-induced obesity, which also correlates with altered pituitary hormone levels. This review will survey evidence for the actions of prostaglandins and other lipid mediators in the H-P axis, and will address the potential for obesity-associated inflammation and n-3 PUFA to impinge on these mechanisms.
Subject(s)
Fatty Acids, Omega-3/physiology , Hypothalamo-Hypophyseal System/physiology , Prostaglandins/physiology , Diet , Dietary Fats , Humans , Hypothalamus/physiology , Inflammation , Obesity , Pituitary Gland/physiology , Pituitary Hormones/biosynthesis , Pituitary Hormones/metabolismABSTRACT
Neurons synthesizing melanin-concentrating hormone (MCH) are described in the posterior hypothalamus of all vertebrates investigated so far. However, their anatomy is very different according to species: they are small and periventricular in lampreys, cartilaginous fishes or anurans, large and neuroendocrine in bony fishes, or distributed over large regions of the lateral hypothalamus in many mammals. An analysis of their comparative anatomy alongside recent data about the development of the forebrain, suggests that although very different, MCH neurons of the caudal hypothalamus are homologous. We further hypothesize that their divergent anatomy is linked to divergence in the forebrain - in particular telencephalic evolution.
Subject(s)
Hypothalamic Hormones/biosynthesis , Hypothalamus/anatomy & histology , Melanins/biosynthesis , Neurons/cytology , Pituitary Hormones/biosynthesis , Vertebrates/anatomy & histology , Animals , Biological Evolution , Brain/anatomy & histology , Fishes/anatomy & histology , Humans , Hypothalamus/physiology , Lampreys/anatomy & histology , Mammals/anatomy & histology , Neurons/physiology , Vertebrates/geneticsABSTRACT
Regulation of energy homeostasis in animals involves adaptation of energy intake to its loss, through a perfect regulation of feeding behavior and energy storage/expenditure. Factors from the periphery modulate brain activity in order to adjust food intake as needed. Particularly, "first order" neurons from arcuate nucleus are able to detect modifications in homeostatic parameters and to transmit information to "second order" neurons, partly located in the lateral hypothalamic area. These "second order" neurons have widespread projections throughout the brain and their proper activation leads them to a coordinated response associated to an adapted behavior. Among these neurons, melanin-concentrating hormone (MCH) expressing neurons play an integrative role of the various factors arising from periphery, first order neurons and extra-hypothalamic arousal systems neurons and modulate regulation of feeding, drinking and seeking behaviors. As regulation of MCH release is correlated to regulation of MCH neuronal activity, we focused this review on the electrophysiological properties of MCH neurons from the lateral hypothalamic area. We first reviewed the knowledge on the endogenous electrical properties of MCH neurons identified according to various criteria which are described. Then, we dealt with the modulations of the electrical activity of MCH neurons by different factors such as glucose, glutamate and GABA, peptides and hormones regulating feeding and transmitters of extra-hypothalamic arousal systems. Finally, we described the current knowledge on the modulation of MCH neuronal activity by cytokines and chemokines. Because of such regulation, MCH neurons are some of the best candidate to account for infection-induced anorexia, but also obesity.
Subject(s)
Hypothalamic Hormones/biosynthesis , Melanins/biosynthesis , Neurons/metabolism , Pituitary Hormones/biosynthesis , Animals , Electrophysiology , Feeding Behavior/physiology , Humans , Hypothalamic Hormones/metabolism , Hypothalamic Hormones/physiology , Hypothalamus/cytology , Melanins/metabolism , Melanins/physiology , Pituitary Hormones/metabolism , Pituitary Hormones/physiologyABSTRACT
Reports have shown that soybeans are goitrogenic. In the present study, we investigated the effects of a high soybean diet in rats that were fed normal or iodine-deficient chow on the regulation of anterior pituitary hormone production. Iodine deficiency alone resulted in thyroid hyperplasia, reduced serum thyroxine levels, and a tendency towards an increase in serum thyroid stimulating hormone (TSH). The combination of a high soybean and low iodine diet (ID + DS) acted synergistically to induce thyroid hypertrophy, reduce serum thyroxine and tri-iodothyronine, and markedly increase serum TSH. Immunohistochemical analysis revealed that rats fed the ID + DS diet exhibited a marked increase in their number of pituitary TSH, prolactin (PRL), and growth hormone (GH) producing cells. Pituitary transcription factor-1 (Pit-1) which is involved in the expression of the TSH, PRL, and GH genes was also increased in ID + DS fed rats. These results suggest that a diet high in soybean products modulates anterior pituitary hormone production by regulating Pit-1 induction, in iodine-deficient animals.
Subject(s)
Diet , Iodine/deficiency , Pituitary Hormones/biosynthesis , Soybean Proteins/administration & dosage , Soybean Proteins/pharmacology , Transcription Factor Pit-1/metabolism , Animals , Body Weight/drug effects , Female , Hypothalamus/cytology , Hypothalamus/drug effects , Immunoblotting , Immunohistochemistry , Organ Size/drug effects , Pituitary Gland/cytology , Pituitary Gland/drug effects , Pituitary Gland/ultrastructure , Pituitary Hormones/blood , Rats , Thyroid Gland/cytology , Thyroid Gland/drug effects , Thyroid Hormones/blood , Thyrotropin-Releasing Hormone/metabolismABSTRACT
Glucagon-like peptide 1 (GLP-1) is produced by neurons in the caudal brainstem that receive sensory information from the gut and project to several hypothalamic regions involved in arousal, interoceptive stress, and energy homeostasis. GLP-1 axons and receptors have been detected in the lateral hypothalamus, where hypocretin neurons are found. The electrophysiological actions of GLP-1 in the CNS have not been studied. Here, we explored the GLP-1 effects on GFP (green fluorescent protein)-expressing hypocretin neurons in mouse hypothalamic slices. GLP-1 receptor agonists depolarized hypocretin neurons and increased their spike frequency; the antagonist exendin (9-39) blocked this depolarization. Direct GLP-1 agonist actions on membrane potential were abolished by choline substitution for extracellular Na+, and dependent on intracellular GDP, suggesting that they were mediated by sodium-dependent conductances in a G-protein-dependent manner. In voltage clamp, the GLP-1 agonist Exn4 (exendin-4) induced an inward current that reversed near -28 mV and persisted in nominally Ca2+-free extracellular solution, consistent with a nonselective cationic conductance. GLP-1 decreased afterhyperpolarization currents. GLP-1 agonists enhanced the frequency of miniature and spontaneous EPSCs with no effect on their amplitude, suggesting presynaptic modulation of glutamate axons innervating hypocretin neurons. Paraventricular hypothalamic neurons were also directly excited by GLP-1 agonists. In contrast, GLP-1 agonists had no detectable effect on neurons that synthesize melanin-concentrating hormone (MCH). Together, our results show that GLP-1 agonists modulate the activity of hypocretin, but not MCH, neurons in the lateral hypothalamus, suggesting a role for GLP-1 in the excitation of the hypothalamic arousal system possibly initiated by activation by viscera sensory input.
Subject(s)
Arousal/physiology , Glucagon/physiology , Hypothalamus/physiology , Intracellular Signaling Peptides and Proteins/analysis , Neurons/physiology , Neuropeptides/analysis , Peptide Fragments/physiology , Protein Precursors/physiology , Synaptic Transmission/drug effects , Action Potentials/drug effects , Afferent Pathways/physiology , Animals , Choline/pharmacology , Digestive System/innervation , Eating/physiology , Exenatide , Genes, Reporter , Glucagon-Like Peptide 1 , Glucagon-Like Peptide-1 Receptor , Glutamic Acid/physiology , Hypothalamic Hormones/biosynthesis , Melanins/biosynthesis , Mice , Mice, Transgenic , Neurons/chemistry , Orexin Receptors , Orexins , Paraventricular Hypothalamic Nucleus/cytology , Paraventricular Hypothalamic Nucleus/drug effects , Patch-Clamp Techniques , Peptide Fragments/pharmacology , Peptides/pharmacology , Pituitary Hormones/biosynthesis , Receptors, G-Protein-Coupled , Receptors, Glucagon/agonists , Receptors, Glucagon/antagonists & inhibitors , Receptors, Glucagon/physiology , Receptors, Neuropeptide , Sodium Channel Blockers/pharmacology , Solitary Nucleus/physiology , Tetrodotoxin/pharmacology , Venoms/pharmacology , Viscera/innervationABSTRACT
BACKGROUND: Peptidergic neurons containing the melanin-concentrating hormone (MCH) and the hypocretins (or orexins) are intermingled in the zona incerta, perifornical nucleus and lateral hypothalamic area. Both types of neurons have been implicated in the integrated regulation of energy homeostasis and body weight. Hypocretin neurons have also been involved in sleep-wake regulation and narcolepsy. We therefore sought to determine whether hypocretin and MCH neurons express Fos in association with enhanced paradoxical sleep (PS or REM sleep) during the rebound following PS deprivation. Next, we compared the effect of MCH and NaCl intracerebroventricular (ICV) administrations on sleep stage quantities to further determine whether MCH neurons play an active role in PS regulation. RESULTS: Here we show that the MCH but not the hypocretin neurons are strongly active during PS, evidenced through combined hypocretin, MCH, and Fos immunostainings in three groups of rats (PS Control, PS Deprived and PS Recovery rats). Further, we show that ICV administration of MCH induces a dose-dependent increase in PS (up to 200%) and slow wave sleep (up to 70%) quantities. CONCLUSION: These results indicate that MCH is a powerful hypnogenic factor. MCH neurons might play a key role in the state of PS via their widespread projections in the central nervous system.
Subject(s)
Central Nervous System/physiology , Hypothalamic Hormones/biosynthesis , Intracellular Signaling Peptides and Proteins , Melanins/biosynthesis , Neurons/physiology , Pituitary Hormones/biosynthesis , Sleep, REM/physiology , Animals , Carrier Proteins/biosynthesis , Cell Count , Central Nervous System/cytology , Central Nervous System/drug effects , Circadian Rhythm/drug effects , Circadian Rhythm/physiology , Dose-Response Relationship, Drug , Electroencephalography , Electromyography , Hypothalamic Hormones/pharmacology , Hypothalamus/cytology , Hypothalamus/metabolism , Injections, Intraventricular , Male , Melanins/pharmacology , Neurons/metabolism , Neuropeptides/biosynthesis , Orexins , Pituitary Hormones/pharmacology , Proto-Oncogene Proteins c-fos/biosynthesis , Rats , Rats, Sprague-Dawley , Sleep/drug effects , Sleep/physiology , Sleep Stages/drug effects , Sleep Stages/physiology , Sleep, REM/drug effectsABSTRACT
Pregnancy and lactation provide excellent models of physiological hyperphagia and hyperprolactinemia. To identify possible factors associated with the increased feeding in these situations, we measured hypothalamic mRNA levels of three orexigenic neuropeptides--NPY, MCH, and orexins--in nonpregnant, pregnant, and lactating rats by in situ hybridization. NPY mRNA content in the arcuate nucleus was significantly increased during pregnancy and lactation. However, MCH and prepro-orexin expression was decreased in both states. 48 or 72 h of fasting in pregnant and lactating rats further elevated NPY mRNA levels and increased the low MCH mRNA content. Surprisingly, no effect was observed in prepro-orexin mRNA levels. Finally, we investigated the possible effect of high PRL levels on these orexigenic signals using a model of hyperprolactinemia induced by pituitary graft. NPY mRNA content was unchanged, but MCH and prepro-orexin mRNA levels were significantly decreased. Our results suggest that the increased NPY expression might be partly responsible for the hyperphagia observed during pregnancy and lactation. MCH and prepro-orexin may be involved in the adaptation of other homeostatic mechanisms and their decreased levels in these physiological settings could be mediated by the elevated circulating PRL levels.
Subject(s)
Hyperphagia/etiology , Hypothalamic Hormones/biosynthesis , Hypothalamus/metabolism , Melanins/biosynthesis , Neuropeptide Y/biosynthesis , Neuropeptides/biosynthesis , Pituitary Hormones/biosynthesis , Protein Precursors/biosynthesis , Animals , Female , Gene Expression Regulation , Hyperphagia/genetics , Hyperphagia/metabolism , Hyperprolactinemia/etiology , Hyperprolactinemia/genetics , Hyperprolactinemia/metabolism , Hypothalamic Hormones/genetics , Hypothalamus/cytology , In Situ Hybridization , Intracellular Signaling Peptides and Proteins , Lactation , Melanins/genetics , Neuropeptide Y/genetics , Neuropeptides/genetics , Orexins , Pituitary Hormones/genetics , Pregnancy , Prolactin/blood , Prolactin/physiology , Protein Precursors/genetics , RNA, Messenger/analysis , RNA, Messenger/metabolism , Rats , Rats, Sprague-DawleyABSTRACT
Many hypothalamic neuropeptides are involved in the regulation of energy homeostasis and feeding behavior. We have investigated whether and to what extent neuropeptide Y (NPY), agouti-related protein (AGRP), melanin-concentrating hormone (MCH), and prepro-orexin (prepro-OX) as well as pro-opiomelanocortin (POMC) and cocaine and amphetamine-regulated transcript (CART) mRNA levels are affected in rat hypothalamus. An experimental model of long-term fasting rat characterized by three metabolic phases from changes in lipid and protein utilization was used. Except for prepro-OX and compared to fed group, starvation induced an increase in the orexigenic gene expressions that was much more marked in phase 3 (by 2.5-, 8.1-, and 13.5-fold for MCH, AGRP, and NPY, respectively) than in phase 2 (by about 1.5-2.2-fold as an average) of fasting. AGRP and NPY mRNA levels were inversely related to body fat content. Anorexigenic gene expression was only slightly affected at both fasting stages. We conclude that the regulation of NPY and AGRP gene expression is primarily involved during late fasting and could mediate the concomitant enhanced drive for refeeding.
Subject(s)
Fasting , Hypothalamus/metabolism , Adipose Tissue/anatomy & histology , Agouti-Related Protein , Animals , Gene Expression Regulation , Hypothalamic Hormones/biosynthesis , Hypothalamic Hormones/genetics , Intercellular Signaling Peptides and Proteins , Intracellular Signaling Peptides and Proteins , Kinetics , Male , Melanins/biosynthesis , Melanins/genetics , Nerve Tissue Proteins/biosynthesis , Nerve Tissue Proteins/genetics , Neuropeptide Y/biosynthesis , Neuropeptide Y/genetics , Neuropeptides/biosynthesis , Neuropeptides/genetics , Nitrogen/urine , Orexins , Pituitary Hormones/biosynthesis , Pituitary Hormones/genetics , Pro-Opiomelanocortin/biosynthesis , Pro-Opiomelanocortin/genetics , Protein Biosynthesis , Protein Precursors/biosynthesis , Protein Precursors/genetics , Proteins/genetics , RNA, Messenger/biosynthesis , Rats , Rats, Sprague-Dawley , Weight LossABSTRACT
The lateral hypothalamus (LH) is implicated in the behavioral actions of drugs of abuse, but the cellular and molecular basis of this role is unclear. Recent identification of neuropeptides localized in LH neurons has allowed for more specific studies of LH function. The LH-specific peptide orexin (hypocretin) has been shown to be important in arousal and sleep regulation. However, orexin cells of the LH project broadly throughout the brain such that orexin may influence other behaviors as well. In this study, we show that orexin neurons, and not nearby LH neurons expressing melanin-concentrating hormone (MCH), have mu-opioid receptors and respond to chronic morphine administration and opiate antagonist-precipitated morphine withdrawal. cAMP response element-mediated transcription is induced in a subset of orexin cells, but not MCH cells, after exposure to chronic morphine or induction of withdrawal. Additionally, c-Fos and the orexin gene itself are induced in orexin cells in the LH during morphine withdrawal. Finally, we show that orexin knock-out mice develop attenuated morphine dependence, as indicated by a less severe antagonist-precipitated withdrawal syndrome. Together, these studies support a role for the orexin system in molecular adaptations to morphine, and demonstrate dramatic differences in molecular responses among different populations of LH neurons.
Subject(s)
Carrier Proteins/metabolism , Hypothalamus/metabolism , Intracellular Signaling Peptides and Proteins , Morphine Dependence/metabolism , Neuropeptides/metabolism , Substance Withdrawal Syndrome/metabolism , Animals , Carrier Proteins/genetics , Chronic Disease , Disease Models, Animal , Drug Implants , Gene Expression Regulation/drug effects , Genes, Reporter , Homozygote , Hypothalamic Hormones/biosynthesis , Hypothalamus/drug effects , Hypothalamus/pathology , Lac Operon , Male , Melanins/biosynthesis , Mice , Mice, Knockout , Mice, Transgenic , Morphine/administration & dosage , Morphine Dependence/pathology , Motor Activity/drug effects , Motor Activity/physiology , Neurons/drug effects , Neurons/metabolism , Neurons/pathology , Neuropeptides/deficiency , Neuropeptides/genetics , Orexin Receptors , Orexins , Pituitary Hormones/biosynthesis , Proto-Oncogene Proteins c-fos/biosynthesis , Receptors, G-Protein-Coupled , Receptors, Neuropeptide , Receptors, Opioid, mu/biosynthesis , Response Elements/genetics , Substance Withdrawal Syndrome/pathologyABSTRACT
Recent studies have provided compelling evidence demonstrating that orexin (also known as hypocretin) neurons play a central role in the pathophysiology of narcolepsy. However, targeted deletion of orexin does not fully mimic the functional deficits induced by selective ablation of these neurons; implying that other secreted signaling molecules expressed in these neurons mediate key aspects of their function. In this study, we demonstrate that orexin neurons display robust expression of neuronal activity-regulated pentraxin (Narp), a secreted neuronal pentraxin, implicated in regulating clustering of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptors. Furthermore, we have found that hypothalamic melanin-concentrating hormone (MCH) neurons, which form a peptidergic pathway thought to oppose the effects of the orexin system, express another neuronal pentraxin, NP1. Thus, these findings suggest that these pathways utilize neuronal pentraxins, in addition to neuropeptides, as synaptic signaling molecules.
Subject(s)
C-Reactive Protein/biosynthesis , Carrier Proteins/biosynthesis , Intracellular Signaling Peptides and Proteins , Nerve Tissue Proteins/biosynthesis , Neurons/metabolism , Neuropeptides/biosynthesis , Animals , Hypothalamic Hormones/biosynthesis , Hypothalamus/cytology , Hypothalamus/metabolism , Immunohistochemistry , In Situ Hybridization , Male , Melanins/biosynthesis , Neurons/cytology , Orexins , Pituitary Hormones/biosynthesis , Rats , Rats, Sprague-DawleyABSTRACT
Agouti-related protein (AgRP) is coexpressed with neuropeptide Y (NPY) in a population of neurons in the arcuate nucleus (ARC) of the hypothalamus and stimulates food intake for up to 7 days if injected intracerebroventricularly. The prolonged food intake stimulation does not seem to depend on continued competition at the melanocortin-4 receptor (MC4R), because the relatively specific MC4R agonist MTII regains its ability to suppress food intake 24 h after AgRP injection. Intracerebroventricular AgRP also stimulates c-Fos expression 24 h after injection in several brain areas, so the neurons exhibiting delayed Fos expression might be particularly important in feeding behavior. Thus we aimed to identify the neurochemical phenotype of some of these neurons in select hypothalamic areas, using double-label immunohistochemistry. AgRP-injected rats ingested significantly more chow (10.2 +/- 0.6 g) vs. saline controls (3.4 +/- 0.7 g) in the first 9 h (light phase) after injection. In the lateral hypothalamus (particularly the perifornical area) 23 h after injection, AgRP induced significantly more Fos vs. saline in orexin-A (OXA) neurons (25.6 +/- 4.9 vs. 4.8 +/- 3.1%), but not in melanin-concentrating hormone (MCH) or cocaine- and amphetamine-regulated transcript (CART) neurons. In the ARC, AgRP induced significantly more Fos in CART (40.6 +/- 5.9 vs. 13.4 +/- 1.8%) but not NPY neurons. In the paraventricular nucleus, there was no significant difference in Fos expression induced by AgRP vs. saline in oxytocin and CART neurons. We conclude that the long-lasting hyperphagia induced by AgRP is correlated with and possibly partially mediated by hyperactive OXA neurons in the lateral hypothalamus and CART neurons in the ARC, but not by NPY and MCH neurons. The substantial increase in light-phase food intake by AgRP supports a role for the arousing effects of OXA. Activation of CART neurons in the ARC (which likely coexpress proopiomelanocortin) could indicate attempts to activate counterregulatory decreases in food intake.
Subject(s)
Hypothalamus/metabolism , Intracellular Signaling Peptides and Proteins , Neurons/metabolism , Proteins/administration & dosage , Proto-Oncogene Proteins c-fos/biosynthesis , Agouti-Related Protein , Animals , Carrier Proteins/biosynthesis , Cell Count , Eating/drug effects , Eating/physiology , Hypothalamic Hormones/biosynthesis , Hypothalamus/cytology , Hypothalamus/drug effects , Immunohistochemistry , Injections, Intraventricular , Intercellular Signaling Peptides and Proteins , Male , Melanins/biosynthesis , Nerve Tissue Proteins/biosynthesis , Neurons/classification , Neurons/cytology , Neurons/drug effects , Neuropeptide Y/biosynthesis , Neuropeptides/biosynthesis , Orexin Receptors , Orexins , Oxytocin/biosynthesis , Phenotype , Pituitary Hormones/biosynthesis , Rats , Rats, Sprague-Dawley , Receptor, Melanocortin, Type 4 , Receptors, G-Protein-Coupled , Receptors, Neuropeptide , Receptors, Peptide/agonistsABSTRACT
The fatty acid synthase inhibitor, C75, acts centrally to reduce food intake and body weight in mice. Here we report the effects of C75 on the expression of key orexigenic [neuropeptide Y (NPY), agouti-related protein (AgRP), and melanin-concentrating hormone] and anorexigenic [pro-opiomelanocortin (POMC) and cocaine-amphetamine-related transcript (CART)] neuropeptide messages in the hypothalami of lean and obese (ob/ob) mice. In lean mice, C75 rapidly and almost completely blocked food intake and prevented fasting-induced up-regulation of hypothalamic AgRP and NPY mRNAs, as well as down-regulation of CART and POMC mRNAs. Thus, in lean mice C75 seems to interrupt the fasting-induced signals that activate expression of NPY and AgRP and suppression of POMC and CART. In obese mice, C75 rapidly suppressed food intake, reduced body weight, and normalized obesity-associated hyperglycemia and hyperinsulinemia. Like its effect in lean mice, C75 prevented the fasting-induced increase of hypothalamic NPY and AgRP mRNAs in obese mice, but had no effect on the expression of POMC and CART mRNAs. The suppressive effect of C75 on food intake in lean mice seems to be mediated both by NPY/AgRP and POMC/CART neurons, whereas in obese mice the effect seems to be mediated primarily by NPY/AgRP neurons. In both lean and obese mice, C75 markedly increased expression of melanin-concentrating hormone and its receptor in the hypothalamus.
Subject(s)
4-Butyrolactone/analogs & derivatives , 4-Butyrolactone/pharmacology , Enzyme Inhibitors/pharmacology , Fatty Acid Synthases/antagonists & inhibitors , Hypothalamus/drug effects , Hypothalamus/metabolism , Neuropeptides/biosynthesis , Animals , Blood Glucose/biosynthesis , Body Weight , Cloning, Molecular , DNA, Complementary/metabolism , Dose-Response Relationship, Drug , Down-Regulation , Food Deprivation , Hypothalamic Hormones/biosynthesis , Insulin/biosynthesis , Melanins/biosynthesis , Mice , Mice, Inbred BALB C , Mice, Obese , Models, Biological , Nerve Tissue Proteins/biosynthesis , Pituitary Hormones/biosynthesis , Pro-Opiomelanocortin/biosynthesis , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Ribonucleases/metabolism , Time Factors , Up-RegulationABSTRACT
Several lines of investigation suggest that the hypothalamic neuropeptide melanin-concentrating hormone (MCH) regulates body weight in mammals. Obese mice lacking functional leptin overexpress the MCH message in the fed or fasted state. Acute intracerebroventricular injection of MCH increases energy intake in rats. Mice lacking the MCH gene are lean. To test the hypothesis that chronic overexpression of MCH in mice causes obesity, we produced transgenic mice that overexpress MCH (MCH-OE) in the lateral hypothalamus at approximately twofold higher levels than normal mice. On the FVB genetic background, homozygous transgenic animals fed a high-fat diet ate 10% more and were 12% heavier at 13 weeks of age than wild-type animals, and they had higher systemic leptin levels. Blood glucose levels were higher both preprandially and after an intraperitoneal glucose injection. MCH-OE animals were insulin-resistant, as demonstrated by markedly higher plasma insulin levels and a blunted response to insulin; MCH-OE animals had only a 5% decrease in blood glucose after insulin administration, compared with a 31% decrease in wild-type animals. MCH-OE animals also exhibited a twofold increase in islet size. To evaluate the contribution of genetic background to the predisposition to obesity seen in MCH-OE mice, the transgene was bred onto the C57BL/6J background. Heterozygote C57BL/6J mice expressing the transgene showed increased body weight on a standard diet, confirming that MCH overexpression can lead to obesity.
Subject(s)
Hypothalamic Hormones/genetics , Hypothalamus/metabolism , Insulin Resistance , Melanins/genetics , Obesity/genetics , Pituitary Hormones/genetics , Adipose Tissue/metabolism , Animals , Blood Glucose/analysis , Body Weight , Eating , Glucose Tolerance Test , Homeostasis , Hypothalamic Hormones/biosynthesis , Leptin/blood , Male , Melanins/biosynthesis , Mice , Mice, Inbred C57BL , Mice, Transgenic , Obesity/metabolism , Pituitary Hormones/biosynthesis , Time FactorsABSTRACT
Using in situ hybridization, the mRNA levels encoding neuropeptide Y (NPY), agouti gene-related protein (AGRP), proopiomelanocortin (POMC), melanin-concentrating hormone (MCH) and hypocretin/orexin (HC/ORX) were investigated in the rat arcuate nucleus (Arc) and lateral hypothalamic area (LHA) 2 h after a single dose of the glucose antimetabolite 2-deoxy-D-glucose (2-DG; 600 mg/kg) or of the fatty acid oxidation inhibitor mercaptoacetate (MA; 600 mumol/kg). Two hours after 2-DG or MA injection food intake was significantly increased. NPY and AGRP mRNA levels in the Arc were increased by 2-DG but not affected by MA, and MCH mRNA levels in the LHA were increased by both antimetabolites. These results suggest that Arc neurons expressing NPY and AGRP are regulated by changes in glucose, but not fatty acid availability, whereas both factors affect MCH neurons in the LHA.
Subject(s)
Carrier Proteins , Deoxyglucose/pharmacology , Hypothalamus/metabolism , Intracellular Signaling Peptides and Proteins , Neuropeptides/biosynthesis , Proteins , Thioglycolates/pharmacology , Agouti-Related Protein , Animals , Arcuate Nucleus of Hypothalamus/drug effects , Arcuate Nucleus of Hypothalamus/metabolism , Eating/drug effects , Hypothalamic Hormones/biosynthesis , Hypothalamus/drug effects , In Situ Hybridization , Intercellular Signaling Peptides and Proteins , Male , Melanins/biosynthesis , Neuropeptide Y/biosynthesis , Neurotransmitter Agents/biosynthesis , Orexins , Pituitary Hormones/biosynthesis , Pro-Opiomelanocortin/biosynthesis , Protein Biosynthesis , RNA, Messenger/biosynthesis , Rats , Rats, Sprague-DawleyABSTRACT
The human GH-releasing hormone (hGHRH) transgenic mouse has a hyperplastic anterior pituitary gland that eventually develops into an adenoma. We showed previously that the number of lactotrophs in the male hGHRH transgenic mouse is increased 2-fold, yet there is no concomitant increase in plasma levels of PRL. To further elucidate underlying changes in lactotroph function in the hGHRH transgenic mouse, the objectives of this study were to 1) examine the relative differences in PRL gene expression in transgenic mice and their siblings, 2) quantify PRL secretion at the level of the individual cell, 3) determine whether tyrosine hydroxylase gene expression and/or activity are altered in the hypothalamus of transgenic mice, and 4) assess dopamine receptor gene expression and functional sensitivity in lactotrophs of transgenic mice. Total PRL messenger RNA (mRNA) levels were increased nearly 5-fold in the hGHRH transgenic mouse, whereas the concentrations of PRL mRNA (PRL mRNA per microg total RNA) were unchanged. In contrast, total PRL contents were unchanged, whereas the concentrations of PRL (micrograms of PRL per mg total protein) were decreased 3-fold. Hypothalamic tyrosine hydroxylase steady state mRNA levels were not altered in the hGHRH transgenic mice, but hypothalamic tyrosine hydroxylase activity was increased 2-fold in transgenic mice. Dopamine D2 receptor mRNA concentrations in the anterior pituitary were increased 2.5-fold in hGHRH transgenic mice, and total pituitary D2 receptor mRNA levels were increased nearly 10-fold. Furthermore, the basal secretory capacity of lactotrophs from transgenic mice was increased significantly at the level of the single cell, and dopamine inhibited the secretion of PRL to a greater extent in hGHRH transgenic mice. Thus, although the total number of lactotrophs is increased 2-fold in hGHRH transgenic mice, the present data are consistent with the hypothesis that increased hypothalamic dopamine synthesis and release coupled with an increase in D2 dopamine receptor gene expression and functional sensitivity in the pituitary result in normal plasma levels of PRL.
Subject(s)
Growth Hormone-Releasing Hormone/biosynthesis , Pituitary Gland, Anterior/physiology , Pituitary Hormones/biosynthesis , Animals , Aromatic Amino Acid Decarboxylase Inhibitors , Chromatography, High Pressure Liquid , Enzyme Inhibitors/pharmacology , Female , Growth Hormone-Releasing Hormone/genetics , Humans , Hydrazines/administration & dosage , Hydrazines/pharmacology , Hypothalamus/enzymology , Hypothalamus/metabolism , Immunoblotting , In Situ Hybridization , Male , Mice , Mice, Transgenic , Pituitary Gland, Anterior/cytology , Pituitary Gland, Anterior/metabolism , Pituitary Hormones/genetics , Pituitary Hormones/metabolism , Prolactin/biosynthesis , Radioimmunoassay , Receptors, Dopamine D2/biosynthesis , Receptors, Dopamine D2/genetics , Tyrosine 3-Monooxygenase/biosynthesis , Tyrosine 3-Monooxygenase/geneticsABSTRACT
In rats, melanin-concentrating hormone (MCH) neurons are mainly located within the lateral hypothalamic area (LHA). This area is known to be involved in the control of feeding and to contain glucose-sensitive cells. As a role for MCH in the regulation of food intake has been reported, we investigated the effects of 2-deoxyglucose (2DG) on MCH expression in cultured LHA slices, to verify if MCH neurons are sensitive to local glucoprivation through a modulation of MCH synthesis. After a 2-10 h 2DG incubation, competitive reverse transcription-polymerase chain reaction (RT-PCR) did not show any variation of MCH mRNA; no change was also observed in MCH immunocytochemical labeling. A slight decrease of MCH mRNA (5-15%) after a 17 h 2DG treatment might be due to a general degradation of neurons induced by long-term glucoprivation. In conclusion, we suggest that MCH neurons are not the glucose-sensitive cells previously described in the LHA and that the signals inducing their previously reported response to glycemia variations do not arise from the LHA itself.